Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Potent orally active antiinflammatory agent by Bristol-Myers Squibb

Aug. 5, 2004

Immunostimulatory effects of loxoribine in monocyte-derived DCs

July 30, 2004

Specific oral PI3K inhibitor blocks neutrophil trafficking and activation in vivo

July 27, 2004

Novel cannabinoid CB2 agonists under study at Sanofi-Synthelabo

July 27, 2004

PBI-1393 activates CTLs and induces IL-2 and IFN-gamma synthesis

July 26, 2004

A recombinant vaccine shows promise in the prevention of SARS

July 26, 2004

Schering claims cannabinoid receptor ligands

July 23, 2004

Cyclosporins for the treatment of immune disorders

July 23, 2004

Sankyo claims immunosuppressive agents

July 22, 2004

Rotarix vaccine receives first global approval in Mexico

July 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.